Established and new treatments for hereditary angioedema: An update
- 30 September 2007
- journal article
- review article
- Published by Elsevier in Molecular Immunology
- Vol. 44 (16), 3858-3861
- https://doi.org/10.1016/j.molimm.2007.06.004
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- C1-inhibitor concentrate home therapy for hereditary angioedema: a viable, effective treatment optionClinical and Experimental Immunology, 2006
- Anaphylactic reaction and antibodies to DX-88 (kallikrein inhibitor) in a patient with hereditary angioedemaJournal of Allergy and Clinical Immunology, 2006
- Interim Results of EDEMA2, a Multicenter, Open-label, Repeat-Dosing Study of Intravenous and Subcutaneous Administration of Ecallantide (DX-88) in Hereditary AngioedemaJournal of Allergy and Clinical Immunology, 2006
- Self-administration of C1-inhibitor concentrate in patients with hereditary or acquired angioedema caused by C1-inhibitor deficiencyJournal of Allergy and Clinical Immunology, 2006
- A phase I study of recombinant human C1 inhibitor in asymptomatic patients with hereditary angioedemaJournal of Allergy and Clinical Immunology, 2005
- Hereditary and acquired angioedema: Problems and progress: Proceedings of the third C1 esterase inhibitor deficiency workshop and beyondJournal of Allergy and Clinical Immunology, 2004
- The pathophysiology of hereditary angioedemaClinical Immunology, 2004
- Safety and efficacy of pasteurized C1 inhibitor concentrate (Berinert® P) in hereditary angioedema: a reviewTransfusion and Apheresis Science, 2003
- Hereditary Angioedema: An Appraisal of 104 CasesThe Lancet Healthy Longevity, 1982
- Replacement Therapy in Hereditary AngioedemaNew England Journal of Medicine, 1980